In a first proof-of-concept study in 2007, we used the insulin tolerance test and showed that copeptin measured during insulin-induced hypoglycemia remains low in patients with DI while increasing in patients with intact posterior pituitary function. The gene discussed is AVP; the disease is Hypoglycemia.